Teva Puerto Rico LLCMarch 3, 2017

FDA 483 - Teva Puerto Rico LLC - March 03, 2017

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Teva Puerto Rico LLC

Record Details

An FDA inspection of Warner Chilcott Company LLC in Fajardo, PR, revealed two significant observations related to manufacturing practices. The firm failed to follow established procedures for stability sample packaging and lacked adequate procedures to prevent microbiological contamination during in-process sampling of non-sterile drug products. These deficiencies indicate a need for improved adherence to and establishment of robust quality control procedures.

Company: Teva Puerto Rico LLC
Inspection Date: March 3, 2017
Product Type: Drugs
Office: Division of Human and Animal Food Operations - East IV
People: Yuexin Wang
German Rivera (FDA Investigator/SJN-DO Pre-Approval Program Manager)

Open in Dashboard

ID · d06f1b78-3ffc-4414-a770-12523ef62c27